Latest from Clara Ashworth
Deals
GSK (GSK) has agreed to acquire U.S.-listed cancer drug developer Nuvalent (NUVL) for $10.6 billion in its largest deal in more than a decade, marking a decisive shift toward oncology under new chief executive Luke Miels as the British…
16 Jun 2026 Business
Centene (CNC) has offered voluntary separation packages to employees across most of its workforce following steep declines in enrollment in its Affordable Care Act health plans, as the lapse of pandemic-era subsidies weighs on its…
16 Jun 2026 Business
Roche (RHHBY) said it will press ahead with a planned €600mn investment in a new diagnostic production facility in Penzberg, Germany, bucking a trend of pharmaceutical companies scaling back spending in the country in response to…
15 Jun 2026 Deals
Drugmaker renews focus on infectious-disease prevention as GLP-1 windfall funds dealmaking spree
9 Jun 2026 Business
Analysts warn that lung cancer focus could be obscuring stronger opportunity in liver and gastric tumours
5 Jun 2026 Deals
Swift transfer eases investor concerns over payment risk in cross-border biotech transactions
5 Jun 2026 Deals
Global biopharma dealmaking is surging toward its strongest year since 2019, with $106 billion in transactions across 201 deals recorded so far in 2026, according to PitchBook data. If the current pace holds, total deal value could exceed…
4 Jun 2026 Business
AbbVie (ABBV) is eliminating 85 positions at its Irvine, California campus, with the cuts set to take effect July 20, according to a filing under the state's Worker Adjustment and Retraining Notification Act. The layoffs affect the…
4 Jun 2026 Business
Swiss drugmaker's deal with UN-backed body could sharply cut cost of single-dose flu treatment across 129 low- and middle-income countries
26 May 2026 Deals
Novartis terminated a manufacturing and facility leasing agreement with Chinese CDMO Porton Pharma Solutions following a dispute tied to regulatory issues at a production site in Slovenia.
25 May 2026 Business
Indiana drugmaker leads both innovation and invention indices for first time as Chinese groups enter the global elite
22 May 2026 Deals
Italian drugmaker enlists CDP Equity to fund transatlantic expansion into rare neurological diseases
21 May 2026 Business
French pharma group backs Alpha-1 detection initiative and expands Pompe disease collaboration
19 May 2026 Business
Kazakhstan has approved an investment agreement underpinning a 42.5bn tenge (around $80mn) pharmaceutical production complex in the central region of Karaganda, in the latest step of a state-driven campaign to reduce the country's reliance…
15 May 2026 Business
Takeda Pharmaceutical (TAK) plans to eliminate around 4,500 jobs in fiscal year 2026 as part of a restructuring programme aimed at centralising corporate functions and reducing costs, the Japanese drugmaker said on Wednesday.
14 May 2026 Deals
Rigel Pharmaceuticals has agreed to acquire exclusive global rights to Veppanu, the first FDA-approved therapy in a new class of cancer drugs that destroys disease-causing proteins rather than blocking them, paying $85mn upfront to Arvinas…
13 May 2026 Business
Milestone Pharmaceuticals, the dual-listed Canadian-US cardiovascular biotech, reported early commercial momentum for its newly launched nasal-spray heart rhythm therapy and confirmed the start of a late-stage trial in a second, larger…
13 May 2026 Deals
Polpharma, Poland's largest pharmaceutical group, has agreed to launch a voluntary public tender offer for Romanian drugmaker Biofarm at a valuation of approximately €270mn, marking one of the most significant cross-border consolidation…
11 May 2026 Deals
GSK has struck an exclusive partnership with Hong Kong-listed Sino Biopharmaceutical to accelerate the launch of bepirovirsen, its closely watched experimental treatment for chronic hepatitis B, in mainland China — the largest single…
11 May 2026 Business
AstraZeneca has announced a £300 million investment in the UK, marking a reversal after previously pausing major projects.
3 May 2026